For the Inventor, By the Inventor

Enter assignee name

Norcross, GA, United States of America

Reddy US Therapeutics, Inc.

USPTO Granted Patents = 19

Forward Citations = 178

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Sivaram Pillarisetti (17 out of 32 patents)

Uday Saxena (17 out of 26 patents)

Christopher W Alexander (14 out of 21 patents)

4. Manojit Pal (14 out of 17 patents)

5. Richard T Timmer (13 out of 14 patents)

6. Gaddam Om Reddy (12 out of 20 patents)

7. Jangalgar Tirupathy Reddy (11 out of 13 patents)

8. Potlapally Rajender Kumar (11 out of 12 patents)

9. Koteswar Rao Yeleswarapu (11 out of 14 patents)

10. Velagala Venkata Rama Murali Krishna Reddy (10 out of 11 patents)

11. Sesha Sridevi Alluri (9 out of 11 patents)

12. Ish Khanna (2 out of 16 patents)

13. Ram Pillarisetti (2 out of 2 patents)

14. Yeleswarapu Koteswar Rao (2 out of 2 patents)

15. Shianlen Cahoon (2 out of 2 patents)

19 patents: Sort by Forward Citations

1. 8008328 - Methods for the treatment of diabetes-associated dyslipdemia (2011-08-30),

2. 7622486 - Pyridine compounds, process for their preparation and compositions containing them (2009-11-24),

3. 7456288 - Heterocyclic compounds and methods of making and using thereof (2008-11-25),

4. 7335656 - Medical devices employing triazine compounds and compositions thereof (2008-02-26),

5. 7332490 - Methods and compositions of novel triazine compounds (2008-02-19),

6. 7332489 - Methods and compositions of novel triazine compounds (2008-02-19),

7. 7332488 - Methods and compositions of novel triazine compounds (2008-02-19),

8. 7273712 - Methods and compositions for detecting compounds that modulate inflammatory responses (2007-09-25),

9. 7268134 - Medical devices employing triazine compounds and compositions thereof (2007-09-11),

10. 7265114 - Methods and compositions of novel triazine compounds (2007-09-04),

11. 7238692 - Medical devices employing triazine compounds and compositions thereof (2007-07-03),

12. 7173032 - Methods and compositions of novel triazine compounds (2007-02-06),

13. 7169785 - Methods and compositions of novel triazine compounds (2007-01-30),

14. 7169784 - Medical devices employing triazine compounds and compositions thereof (2007-01-30),

15. 7163943 - Methods and compositions of novel triazine compounds (2007-01-16),

Reddy US Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies to improve the lives of patients. Our mission is to address unmet medical needs and deliver high-quality, affordable medicines to patients in the United States. With a strong commitment to research and development, we strive to bring novel treatments to the market that target various therapeutic areas, including oncology, cardiovascular diseases, and infectious diseases. Through collaboration and a passion for advancing healthcare, Reddy US Therapeutics aims to make a positive impact on patients' lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

19 Patents

#30 in Norcross, GA

#330 in Georgia

#16,592 in US

#31,670 in the World

Norcross, GA, United States of America

Reddy US Therapeutics, Inc.

Forward Citations = 178

34 inventors:

Sivaram Pillarisetti (17 out of 32 patents)

Uday Saxena (17 out of 26 patents)

Christopher W Alexander (14 out of 21 patents)

4. Manojit Pal (14 out of 17 patents)

5. Richard T Timmer (13 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…